The pericarditis drugs market is estimated to serve good growth opportunities across the assessment period of 2021-2031. The escalating adoption of dual therapy, product approvals, advent of biologics, and the increasing cases of idiopathic pericarditis will bring immense growth opportunities for the pericarditis drugs market during the forecast period of 2021-2031.
• The extensive advancements in the treatment and the diagnosis of cardiovascular diseases will bring exponential growth for the pericarditis drugs market. The advancements in the biologics sector will also bring expansive growth prospects during the tenure of 2021-2031.
• Research and development activities have an important part in the growth of the pericarditis drugs market. The rising use of these drugs has led to intense concentration of the players on research. The activities help in deriving new formulations that boost the growth opportunities across the pericarditis drugs market to a considerable extent. All these factors bode well for the growth of the pericarditis drugs market.
• Strategic collaborations are crucial for the pericarditis drugs market. The players are involved in mergers and acquisitions for cementing their foothold across the pericarditis drugs market, eventually sowing the seeds of growth.
Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B...
Pericardium, a thin sac, surrounds the human heart. The pericardial cavities take place between the fluid-filled layers (fibrous and serous pericardium). The key function of the pericardium is to safeguard and lubricate the heart in place within the cavity of the chest. Other than this, it also prevents the heart from stretching too much, restrains friction with other tissues around during heart-beating, and protects it from infections. But once pericardium is inflamed with fluid it can harm and disturb the routine functions of the heart. The swelling in the pericardium is pericarditis which can be of two types: acute and chronic. A rapid rise in emergency cases due to chest pain has fueled the pericarditis drugs market.
In the condition of constrictive pericarditis along with shortness of breath, swelling of abdomen, legs, and feet, and heart palpitations, immediate medication is required. So as per laboratory investigations, non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or aspirin should be recommended to patients. As an adjunct to NSAIDs, colchicine is also suggested as first-line therapy to its treatment. With multiple medication options available for the treatment of disease, the pericarditis drugs market may witness new avenues. The arrival of biologics, adoption of dual therapy, marked prevalence of idiopathic pericarditis, and product approvals are responsible for the anticipated expansion of the pericarditis drugs market.
Request COVID Analysis on Pericarditis Drugs Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=c...
Pericarditis Drugs Market: Introduction
• Pericarditis is inflammation of the pericardium. Pericardium is two thin layers of a sac like structure of tissues that surrounds the heart. The pericardium holds the heart in place and helps it work. It has small amount of fluid that keeps both the layers separated from each other so that there is no friction between the layers. Pericarditis often causes chest pain and other symptoms. The harsh chest pain associated with pericardium occurs when the layers of the pericardium rub against each other. Pericarditis usually begins suddenly, but does not last for long.
• Chronic pericarditis is when symptoms related to pericarditis develop more gradually or persist. Most cases of pericarditis are mild and usually improve on their own. Common symptoms related of pericarditis are cough, leg or abdominal swelling, low-grade fever, heart palpitations, shortness of breath when reclining, an overall sense of weakness, feeling sick or fatigue, and sharp, piercing chest pain. Pericarditis can be diagnosed with the help of electrocardiogram, echocardiogram, physical examination, cardiac MRI, and reported symptoms.
Request Customization on Pericarditis Drugs Market Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=C...
Key Drivers, Restrains, and Opportunities of Global Pericarditis Drugs Market
• Rise in prevalence of cardiovascular diseases and pericarditis is expected to drive the demand for pericarditis drugs. According to Cureus, an open access medical journal for a new generation of doctors and patients, acute pericarditis is the most common disease in several clinical settings. The incidence of acute pericarditis has been reported to be between 0.1% and 0.2% of hospitalized patients, and 5% of the patients were admitted to the emergency department with non-ischemic chest pain. Moreover, cardiovascular diseases account for 17.9 million deaths globally each year, constituting an estimated 31% of all deaths. Over 75% of cardiovascular deaths occur in low- and middle-income countries.
• Adoption of dual therapy for the treatment of idiopathic pericarditis is a key factor propelling the global pericarditis drugs market. Conventionally, aspirin as monotherapy is used to treat acute pericarditis. However, clinical trials are being carried out for dual therapy with the combination of two drugs — aspirin with colchicine — for the treatment of pericarditis. The results have shown that combination therapy is effective in reducing the recurrence rate of pericarditis compared to conventional monotherapy.
• Therefore, adoption of dual therapy such as aspirin with colchicine is anticipated to increase due to rise in prevalence of idiopathic pericarditis with repeated episodes. However, side effects of anti-inflammatory drugs, presence of misbranded drugs, surgical intervention, and stringent government rules and regulations are expected to hamper the growth of the global pericarditis drugs market during the forecast period.
Pre Book Pericarditis Drugs Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=6809...
North America to Capture Major Share of Global Pericarditis Drugs Market
• North America is anticipated to account for major share of the global pericarditis drugs market during the forecast period. This is attributed to large number of people diagnosed with cardiac disorders and substantial R&D and health care spending. Moreover, increase in awareness about cardiovascular disorders is expected to boost the growth of the market in North America.
• The pericarditis drugs market in Asia Pacific is likely to grow at a rapid pace during the forecast period owing to rise in number of cardiac surgeries, increase in patients with cardiovascular disorders, and expanding health care infrastructure
Key Players Operating in Global Pericarditis Drugs Market
The global pericarditis drugs market is moderately fragmented due to the presence of larger number of international as well as local players. These players hold major market share in their respective regions.
Major players operating in the global pericarditis drugs market are:
• AstraZeneca plc
• Bayer AG
• Johnson & Johnson
• Pfizer, Inc.
• Takeda Pharmaceutical Co. Ltd.
• Other prominent players
About Us Section:
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyse information. Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the unified market intelligence engine. Sign Up for a 7 day free trial!
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/